Hannover Medical School is developing optimized psycho-oncological care through an Interdisciplinary Care Algorithm (OptiScreen)
Photo by Lesly Juarez
Hannover Medical School is commencing recruitment for the clinical trial of the Optimized Psycho-oncological Care Through an Interdisciplinary Care Algorithm.
The adequate, needs-oriented psycho-oncological care contributes to reducing the burden on cancer patients and their relatives and to improving the quality of life. There is still a need for clarification regarding the need and the determination of psychosocial needs. This multi-center study (Hanover, Leipzig and Dresden) aims at a professionalization of psychosocial screening, in order to enable thus an exact and need-based allocation to psycho-oncological support. The optimization and professionalization of the psychosocial screening process shall be achieved by a training of oncological nursing and development of an interdisciplinary care algorithm. The aim is to examine whether "OptiScreen" increases the targeted and needs-based allocation to psycho-oncology.
The study will include inpatients from the visceral oncology centers at the three sites who have the necessary cognitive, physical and linguistic abilities. The data collected will include psychological stress, disease management/treatment, quality of life and treatment satisfaction of persons with oncological diseases. In addition, the needs for information and support, the practicability as well as the allocation to psycho-oncological care and its utilization will be surveyed.
The trial officially began on the April 1, 2020 and is planned to complete on December 31, 2022.
The Hannover Medical School (Medizinische Hochschule Hannover abbreviated MHH in German), founded in 1965, is a university medical centre in the city of Hanover, in Germany, part of a regional medical network.
Universitätsklinikum Leipzig and UniversitätsKrebsCentrum Dresden are the collaborators in this clinical trial.
The link to the complete study profile: https://ichgcp.net/clinical-trials-registry/NCT04638699
